Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
ACS Medicinal Chemistry Letters
|
January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose Projections
H Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.
ACS Medicinal Chemistry Letters
|
February 16, 2023
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's Disease
Anthony J Roecker, Kathy M Schirripa, H Marie Loughran, et al.
Viruses
|
July 27, 2024
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling
Nadine Alvarez, Gregory C Adam, John A Howe, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
April 21, 2017
Prospective Assessment of Virtual Screening Heuristics Derived Using a Novel Fusion Score
Dante A Pertusi, Gregory O'Donnell, Michelle F Homsher, et al.
Plos One
|
February 6, 2026
Efficacy evaluation of the S-adenosylhomocysteine hydrolase inhibitor MSD-914 in rhesus macaques (Macaca Mulatta) challenged with Ebola virus by the intramuscular route
Sara C Johnston, Anthony T Ginnetti, Nancy A Twenhafel, et al.
Cell Chemical Biology
|
October 27, 2019
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
Cell Chemical Biology
|
February 19, 2021
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
ACS Chemical Biology
|
August 31, 2022
A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells
Keith P Moore, Adam G Schwaid, Matthew Tudor, et al.
Journal of Medicinal Chemistry
|
February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic
Valerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
ACS Medicinal Chemistry Letters
|
January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose Projections
H Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.
ACS Medicinal Chemistry Letters
|
February 16, 2023
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's Disease
Anthony J Roecker, Kathy M Schirripa, H Marie Loughran, et al.
Viruses
|
July 27, 2024
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling
Nadine Alvarez, Gregory C Adam, John A Howe, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
April 21, 2017
Prospective Assessment of Virtual Screening Heuristics Derived Using a Novel Fusion Score
Dante A Pertusi, Gregory O'Donnell, Michelle F Homsher, et al.
Plos One
|
February 6, 2026
Efficacy evaluation of the S-adenosylhomocysteine hydrolase inhibitor MSD-914 in rhesus macaques (Macaca Mulatta) challenged with Ebola virus by the intramuscular route
Sara C Johnston, Anthony T Ginnetti, Nancy A Twenhafel, et al.
Cell Chemical Biology
|
October 27, 2019
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
Cell Chemical Biology
|
February 19, 2021
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
ACS Chemical Biology
|
August 31, 2022
A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells
Keith P Moore, Adam G Schwaid, Matthew Tudor, et al.
Journal of Medicinal Chemistry
|
February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic
Valerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Page
of 3